APBI: 30 Gy
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Ontario Clinical Oncology Group (OCOG)
Overview
APBI: 30 Gy is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
APBI: 30 Gy clinical trials
Explore related
Medical disclaimer. This page summarizes research about APBI: 30 Gy for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.